What is MedAptus?
MedAptus operates as a specialized provider of revenue cycle and patient assignment software, engineered to enhance revenue capture and streamline clinical workflows. The company's core product suite, which includes Charge Pro, Assign, and Charge Infusion, serves as a vital bridge between clinical operations and financial performance. By integrating directly with Electronic Health Records (EHR), MedAptus enables hospitals and physician groups to automate charge capture and improve coding accuracy. This technological intervention is essential for healthcare organizations aiming to mitigate administrative overhead and reallocate resources toward patient care. As a key player in the health-tech ecosystem, MedAptus leverages intelligent software to solve systemic inefficiencies, positioning itself as an indispensable partner for modern healthcare delivery systems.
How much funding has MedAptus raised?
MedAptus has raised a total of $8.8M across 3 funding rounds:
Series A
$2.5M
Unspecified
$6M
Debt
$350K
Series A (2000): $2.5M with participation from Leo Capital Holdings
Unspecified (2009): $6M led by Boston Millennia Partners
Debt (2020): $350K supported by PPP
Key Investors in MedAptus
Leo Capital Holdings
A private venture investor focused on consumer-oriented technology and applications, providing active involvement to help build value in early and later-stage companies.
Boston Millennia Partners
A private equity firm specializing in high-growth healthcare and life sciences companies, leveraging extensive operational and financial expertise to drive portfolio success.
PPP
Public-Private Partnership
What's next for MedAptus?
With the support of its recent major strategic investment, MedAptus is well-positioned to accelerate its product development roadmap and expand its footprint in the enterprise healthcare market. The company's focus on intelligent automation and workflow optimization remains highly relevant as healthcare providers face increasing pressure to improve margins while maintaining high standards of care. Future growth will likely center on deepening EHR integrations and potentially expanding its suite of analytical tools to provide more granular insights into clinical and financial performance. By leveraging its established market presence and historical backing, MedAptus is poised to continue its trajectory as a leader in revenue cycle innovation, driving digital transformation across the clinical enterprise.
See full MedAptus company page
